Vendor profile
Research · US · —
Guangzhou Aoyu
B+
Composite 7.8 / 10
Last updated 2026-10-19. Composite is computed from the live database; missing sub-scores redistribute weight across the others.
Peptide breakdown
| Peptide | Score | Lab quality | Tests | Purity | Qty var. | $/mg verified | Last test | Ranking |
|---|---|---|---|---|---|---|---|---|
| Tirzepatide | 7.8B+ |
7.3 | 8 | — | — | — | — | view |
| BPC-157 | — |
— | 0 | — | — | — | — | view |
| GHK-Cu | — |
— | 0 | — | — | — | — | view |
| Ipamorelin | — |
— | 0 | — | — | — | — | view |
| MOTS-c | — |
3.1 | 2 | — | — | — | — | view |
| PT-141 | — |
— | 0 | — | — | — | — | view |
| Retatrutide | — |
7.8 | 5 | — | — | — | — | view |
| Tesamorelin | — |
4.1 | 3 | — | — | — | — | view |
COA transparency
- ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
- ○ Both HPLC and mass spec shown (pending)
- ○ Endotoxin or sterility data shown (pending)
- ○ At least one COA independently cross-checked (pending)
- ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Guangzhou Aoyu against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.